PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-05-19

Date Title Company
19-May-2023 Anticoagulants Market: Revolutionizing Blood Clot Prevention and Treatment | Boehringer Ingelheim, Janssen Pharmaceuticals, Pfizer The Wire Times
19-May-2023 Rising Demand for EEG Equipment: Market Insights and Projections | Compumedics, Nihon Kohden, GE Healthcare The Wire Times
19-May-2023 Radiation Oncology Market Share Will Increase at 4.6% CAGR Globally by 2030 | By AMR The Wire Times
19-May-2023 Epigenomics AG: Member of the Executive Board and Chief Scientific Officer Andrew Lukowiak Resigns Epigenomics AG
19-May-2023 Epigenomics AG: Changes in the Management Epigenomics AG
19-May-2023 Celltrion Healthcare Launches IBD Awareness Campaign in Collaboration With Leading Patient Organisation, EFCCA, for World IBD Day 2023 Celltrion Healthcare
19-May-2023 Orgenesis to participate in Benchmark’s third Annual Healthcare House Call Virtual 1x1 Investor Conference on May 23, 2023 Orgenesis
19-May-2023 Sarcoma Drugs Market Update 2023: Projected to Grow at a CAGR of 8.3% by 2031, Report The Wire Times
19-May-2023 Speech Therapy Market is Anticipated to Witness Substantial Expansion, CAGR of 5.6%, Claims AMR The Wire Times
19-May-2023 CureVac Announces Developments in Patent Litigation with Pfizer/BioNTech CureVac
19-May-2023 Antibody Drug Conjugates Market : Opportunity Analysis and Industry Forecast 2030 | CAGR 12.9% The Wire Times
19-May-2023 Pain Management Drugs Market Projected to Grow at a CAGR of 3.8% by 2027, Report The Wire Times
19-May-2023 Oral Cancer Treatment Market Size Projected to Cross Market Value of $2.7 Billion by 2030 The Wire Times
19-May-2023 Cancer Gene Therapy Market : Opportunity Analysis and Industry Forecast 2030 | CAGR 23.3% The Wire Times
19-May-2023 Celltrion Healthcare launches IBD awareness campaign in collaboration with leading patient organisation, EFCCA, for World IBD Day 2023 Celltrion Healthcare
19-May-2023 Cell and Gene Therapy CDMO Targets North American Growth with Major US Acquisition uBriGene
19-May-2023 NICE recommends Bayer’s NUBEQA®▼ (darolutamide) + ADT in combination with docetaxel for the treatment of patients with metastatic hormone-sensitive prostate cancer (mHSPC) Bayer
19-May-2023 OMICSEDGE FORMS STRATEGIC PARTNERSHIP WITH ALMADEN GENOMICS TO STREAMLINE DRUG DISCOVERY OmicsEdge
19-May-2023 Exploring Healthcare Chatbots Market 2023: Predicted to Surpass USD 345.3 Million by 2026, Claims AMR The Wire Times
19-May-2023 Actinic Keratosis Treatment Market Forecast : Key Factors Driving Rapid Growth towards $1,558 Million by 2026 The Wire Times